Skip to main content
Log in

Improved Staging of Cervical Metastases in Clinically Node-Negative Patients With Head and Neck Squamous Cell Carcinoma

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: The management of the N0 neck in oral and oropharyngeal cancer is often determined by the risk of metastases related to features of the primary tumor. Where the risk of metastases is >20%, elective neck dissection (END) has been advocated. This study reviewed clinical staging, surgical staging, pathologic staging, and histopathologic parameters to determine the prediction of nodal metastases and micrometastases in patients with head and neck squamous cell carcinoma.

Methods: A prospective series of 61 clinically neck node–negative patients undergoing surgical resection of a T1/2 intraoral or oropharyngeal invasive squamous cell carcinoma and surgical staging of the neck, with sentinel node biopsy (SNB) alone or SNB-assisted END, between June 1998 and March 2002 were included in this study.

Results: Pathologic upstaging of the clinically N0 neck occurred in 27 (44%) of 61 patients. Routine pathology with hematoxylin and eosin upstaged disease in 22 of 27 patients (sensitivity of 81%). Five patients with micrometastasis were staged pN1mi after stepped serial sectioning and immunohistochemistry. Tumor thickness, a noncohesive invasive front, and perineural and bone invasion were all histological predictors for cervical metastases. Five patients with micrometastases were staged pN1mi.

Conclusions: Both clinical staging and routine pathologic staging underestimate the presence of nodal metastases. Staging with either SNB alone or SNB-assisted END shows promise in the management of the N0 neck by identifying patients with micrometastases (pN1mi).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haddadin KJ, Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999;21:517–525.

    Article  PubMed  CAS  Google Scholar 

  2. Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993;15:308–312.

    Article  PubMed  CAS  Google Scholar 

  3. Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous cell carcinoma of the oral tongue. Am J Surg 1993;166:360–365.

    Article  PubMed  CAS  Google Scholar 

  4. Yuen APW, Wei WI, Wong YM, Tang KCT. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997;19:583–588.

    Article  PubMed  CAS  Google Scholar 

  5. Kligerman J, Lima RA, Soares JR, et al. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994;168:391–394.

    Article  PubMed  CAS  Google Scholar 

  6. Forastiere AA, Ang K, Argiris A, et al. NCCN practice guidelines for cancer of the head and neck, version 1.2002. Rockville, PA. Available at: http://www.nccn.org/physician_gls/index.html. Accessed April 11, 2003.

  7. O’Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 2000;126:360–365.

    PubMed  CAS  Google Scholar 

  8. Woolgar JA, Beirne JC, Vaughan ED, Lewis-Jones HG, Scott J, Brown JS. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg 1995;24:30–37.

    Article  PubMed  CAS  Google Scholar 

  9. Stern WB, Silver CE, Zeifer BA, Persky MS, Heller KS. Computed tomography of the clinically negative neck. Head Neck 1990;12:109–113.

    Article  PubMed  CAS  Google Scholar 

  10. Friedman M, Mafee MF, Pacella BL Jr., Strorigl TL, Dew LL, Toriumi DM. Rationale for elective neck dissection in 1990. Laryngoscope 1990;100:54–59.

    PubMed  CAS  Google Scholar 

  11. Moreau P, Goffart Y, Collignon J. Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1990;116:1190–1193.

    PubMed  CAS  Google Scholar 

  12. van den Brekel MW, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11–17.

    PubMed  CAS  Google Scholar 

  13. John DG, Anaes FC, Williams SR, et al. Palpation compared with ultrasound in the assessment of malignant cervical lymph nodes. J Laryngol Otol 1993;107:821–823.

    PubMed  CAS  Google Scholar 

  14. Righi PD, Kopecky KK, Caldemeyer KS, Ball VA, Weisberger EC, Radpour S. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997;19:604–610.

    Article  PubMed  CAS  Google Scholar 

  15. Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996;198:819–823.

    PubMed  CAS  Google Scholar 

  16. Kau RJ, Alexiou C, Laubenbacher C, Werner M, Schwaiger M, Arnold W. Lymph node detection of head and neck squamous cell carcinomas by positron emission tomography with fluorodeoxyglucose F 18 in a routine clinical setting. Arch Otolaryngol Head Neck Surg 1999;125:1322–1328.

    PubMed  CAS  Google Scholar 

  17. Stokkel MP, ten Broek FW, Hordijk GJ, Koole R, van Rijk PP. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography. Ann Surg 2000;231:229–234.

    Article  PubMed  CAS  Google Scholar 

  18. Ewing MR, Martin H. Disability following radical neck dissection. Cancer 1952;5:873–883.

    Article  PubMed  CAS  Google Scholar 

  19. Shone GR, Yardley MP. An audit into the incidence of handicap after unilateral radical neck dissection. J Laryngol Otol 1991;105:760–762.

    PubMed  CAS  Google Scholar 

  20. Kuntz AL, Weymuller EA. Impact of neck dissection on quality of life. Laryngoscope 1999;109:1334–1338.

    Article  PubMed  CAS  Google Scholar 

  21. Saffold SH, Wax MK, Nguyen A, et al. Sensory changes associated with selective neck dissection. Arch Otolaryngol Head Neck Surg 2000;126:425–428.

    PubMed  CAS  Google Scholar 

  22. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392–399.

    PubMed  CAS  Google Scholar 

  23. Alex JC, Krag DN. Gamma-probe guided localization of lymph nodes. Surg Oncol 1993;2:137–143.

    Article  PubMed  CAS  Google Scholar 

  24. Shoaib T, Soutar DS, Prosser JE, et al. A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 1999;21:728–733.

    Article  PubMed  CAS  Google Scholar 

  25. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 2001;91:2077–2083.

    Article  PubMed  CAS  Google Scholar 

  26. Ross GL, Shoaib T, Soutar DS, et al. The first international conference on sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002;9:406–410.

    Article  PubMed  CAS  Google Scholar 

  27. Ross GL, Shoaib T, Soutar DS, et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002;128:1287–1291.

    PubMed  Google Scholar 

  28. Ross GL, Soutar DS, Shoaib T, et al. The ability of lymphoscintigraphy to direct sentinel node biopsy in the clinically N0 neck for patients with head and neck squamous cell carcinoma. Br J Radiol 2002;75:950–958.

    PubMed  CAS  Google Scholar 

  29. The Royal College of Pathologists. Minimum dataset for head and neck carcinoma histopathology reports. London: The Royal College of Pathologists, 1998.

    Google Scholar 

  30. Ferlito A, Devaney KO, Rinaldo A, Devaney SL, Carbone A. Micrometastases: have they an impact on prognosis?. Ann Otol Rhinol Laryngol 1999;108:1185–1189.

    PubMed  CAS  Google Scholar 

  31. Wilkinson EJ, Hause L. Probability in lymph node sectioning. Cancer 1974;33:1269–1274.

    Article  PubMed  CAS  Google Scholar 

  32. Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 1999;37:181–186.

    Article  PubMed  CAS  Google Scholar 

  33. Hermanek P, Hutter RVP, Sobin LH, Wittekind C. Classification of isolated tumour cells and micrometastasis. Cancer 1999;86:2668–2673.

    Article  PubMed  CAS  Google Scholar 

  34. Robbins KT. Classification of neck dissection: current concepts and future considerations. Otolaryngol Clin North Am 1998;31:639–655.

    Article  PubMed  CAS  Google Scholar 

  35. van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999;26:S43–9.

    Article  PubMed  CAS  Google Scholar 

  36. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;6:2253–2260.

    Google Scholar 

  37. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC Jr. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999;86:990–996.

    Article  PubMed  CAS  Google Scholar 

  38. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph node metastases in the management of breast cancer. International Breast Cancer Study Group. Lancet 1999;354:896–900.

    Article  PubMed  CAS  Google Scholar 

  39. Ishida K, Katsuyama T, Sugiyama A, Kawasaki S. Immunohistochemical evaluation of lymph node micrometastases from gastric carcinomas. Cancer 1997;79:1069–1076.

    Article  PubMed  CAS  Google Scholar 

  40. O’Sullivan GC, Collins JK, Kelly J, Morgan J, Madden M, Shanahan F. Micrometastases: marker of metastatic potential or evidence of residual disease?. Gut 1997;40:512–515.

    PubMed  CAS  Google Scholar 

  41. Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler H, Siewert JR. Micrometastasis and tumour cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Frequency, associated tumour characteristics, and impact on prognosis. Cancer 1998;83:858–866.

    Article  PubMed  CAS  Google Scholar 

  42. Glickman JN, Torres C, Wang HH, et al. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma. Cancer 1999;85:769–778.

    Article  PubMed  CAS  Google Scholar 

  43. Yokoyama N, Shirai Y, Hatakeyama K. Immunohistochemical detection of lymph node micrometastases from gall bladder carcinoma using monoclonal anticytokeratin antibody. Cancer 1999;85:1465–1469.

    Article  PubMed  CAS  Google Scholar 

  44. Ambrosch P, Brinck U. Detection of nodal micrometastasis in head and neck cancer by serial sectioning and immunostaining. Oncology (Huntingt) 1996;10:1221–1226.

    CAS  Google Scholar 

  45. Turner RR. Histopathologic assessment of the sentinel lymph node in breast cancer. Ann Surg Oncol 2001;8:56S–59S.

    PubMed  CAS  Google Scholar 

  46. Cochran AJ, Huang RR, Guo J, Wen DR. Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol 2001;8:13S–17S.

    PubMed  CAS  Google Scholar 

  47. van Diest PJ, Torrenga H, Meijer S, Meijer CJ. Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol 2001;20:238–245.

    Article  PubMed  Google Scholar 

  48. van den Brekel MW, Stel HV, van der Valk P, van der Waal I, Meyer CJ, Snow GB. Micrometastases from squamous cell carcinoma in neck dissection specimens. Eur Arch Otorhinolaryngol 1992;249:349–353.

    Article  PubMed  Google Scholar 

  49. Sobin LH, Wittekind C, eds. International Union Against Cancer: TNM Classification of Malignant Tumours. 6th ed. New York: Wiley, 2002.

    Google Scholar 

  50. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635–3648.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. L. Ross MRCSEd.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ross, G.L., Soutar, D.S., MacDonald, D.G. et al. Improved Staging of Cervical Metastases in Clinically Node-Negative Patients With Head and Neck Squamous Cell Carcinoma. Ann Surg Oncol 11, 213–218 (2004). https://doi.org/10.1245/ASO.2004.03.057

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2004.03.057

Key Words

Navigation